However, in an appearance before a commission of the European Parliament the head of the European Medicines Agency (EMA) He warned that the decision on the eventual need for more injections should be made by other agencies.
European regulators “don’t yet know” whether current vaccines are still effective against the omicron variant, and according to Cooke it will take about two weeks to determine if new vaccines are necessary.
“First you have to decide if this is necessary, and it is not for the European Medicines Agency to decide”, he emphasized.
“This is a decision that will take into account the epidemiological situation, the efficacy of current vaccines against the variant, the circulation of the variant in Europe and many other factors,” he added.
Those responsible for the modern pharmaceutical company have expressed their pessimism about the efficiency of the existing vaccines against the omicron variant of the coronavirus.
For their part, Pfizer and Johnson & Johnson (J&J) laboratories announced on Monday that, like Moderna, they began working on a new version of their vaccine aimed more specifically at omicron case current vaccines are not effective enough.
So far, the EMA has approved four adult vaccines in the European Union: those from Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson.
A decision on a fifth vaccine, from the US company Novavax, is expected “in a few weeks,” said Cooke.
Source From: Ambito
David William is a talented author who has made a name for himself in the world of writing. He is a professional author who writes on a wide range of topics, from general interest to opinion news. David is currently working as a writer at 24 hours worlds where he brings his unique perspective and in-depth research to his articles, making them both informative and engaging.
